Blood and Lymphatic System Dyslipidemia

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Dyslipidemia Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Dyslipidemia Projects
--AstraZeneca Plc
--Abbott Laboratories
--Genfit
--Dr Reddys Laboratories Ltd
--Japan Tobacco Inc.
--GlaxoSmithKline plc
--Kemia, Inc
--Karo Bio AB
--Liponex Inc.
--LifeCycle Pharma
--Quark Pharmaceuticals, Inc.
--Metabolex, Inc.
--Sanofi-Aventis
--Roche Holdings Ltd
--Sciele Pharma, Inc.
--Sanwa Kagaku Kenkyusho Co., Ltd.
--Surface Logix, Inc.
--Solvay S.A.
--Zydus Cadila Healthcare Limited
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Dyslipidemia Projects
--Amarin Corporation plc
--AbGenomics Corporation
--AVANIR Pharmaceuticals
--AstraZeneca Plc
--Forbes Medi-Tech Inc
--Dr Reddys Laboratories Ltd
--Nippon Shinyaku Co., Ltd.
--GlaxoSmithKline plc
--Ranbaxy Laboratories Ltd.
--QuatRx Pharmaceuticals
--Sanofi-Aventis
--Roche Holdings Ltd

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View